Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
To own Sartorius, you really need to believe in the long-term demand for bioprocessing and advanced therapies, and in the company’s ability to monetize its heavy investments in new facilities and platforms like Eveo. The latest half-year results, with a clear uplift in profitability versus only modest sales growth, slightly strengthen the near-term catalyst around margin recovery and reassure on management’s 2026 guidance. That said, the share price has been weak this year despite the earnings improvement, suggesting the market is still focused on risks such as high leverage and a valuation multiple well above peers. The new numbers don’t remove those concerns, but they do reduce the risk that earnings roll over again in the short term.
However, one key financial risk still stands out that investors should not ignore. Sartorius' shares have been on the rise but are still potentially undervalued by 26%. Find out what it's worth.Explore 2 other fair value estimates on Sartorius - why the stock might be worth just €262.67!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com